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Introduction: The study aimed to evaluate function of the left atrium (LA) and
of the left atrial appendage (LAA) after myocardial infarction (MI) complicated
by intracardiac conduction disturbances. 
Material and methods: The study comprised 59 patients with persistent post-
myocardial distal blocks, who were allocated to one of the three following
subgroups: study group I – 20 patients with left bundle branch block (LBBB);
study group II – 20 patients with right bundle branch block (RBBB), and study
group III –19 pts with left anterior hemiblock (LAHB). The control groups included
patients with MI in their history and no BBBs (19 pts – group IV) and clinically
healthy people (16 patients – group V). The parameters of LA and LAA systolic
function were determined by means of transthoracic (TTE) and transoesophageal
echocardiography (TOE). 
Results: We showed that patients who experienced myocardial infarction not
complicated with conduction disturbances expressed compensatory LA systolic
function enhancement. In patients with post-myocardial RBBB and LAHB
significant enhancement of LA systolic function was observed as well but it was
expressed to a lesser degree. There was also a tendency towards deterioration
of LA systolic function in patients with post-myocardial LBBB. LBBB did not affect
LAA systolic function negatively. 
Conclusions: Parameters of LAA systolic function showed its enhancement in
all patients after myocardial infarction irrespective of whether it was complicated
by conduction disturbances.
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Introduction
The cardiac conduction system is responsible for generation and
conduction of synchronized bioelectric stimuli in the heart, which results
in coordinated physiological and effective heart work. Defects of this
system affect and deteriorate left and right ventricular as well as atrial
function [1-3].
Bundle branch blocks (BBBs) are known to be associated with higher
mortality in patients with acute myocardial infarction (MI) and with
congestive heart failure (CHF) [4-8]. There are limited data on the influence
of BBBs on prognosis in ischaemic heart disease. BBBs are the cause of
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function deterioration [9, 10]. Little is known about
left atrial function and about left atrial appendage
function in patients with post-myocardial BBBs.
It is known that left atrial (LA) systolic function
is enhanced in hypertension [11], in CHF [12, 13], and
post MI [14]. LA and left atrial appendage (LAA)
function may be a useful indicator of the degree of
left ventricular (LV) impairment and may determine
the prognosis [15-22]. 
Poor physical efficiency, impaired LV function and
intraventricular conduction prolongation are
classical, well established indications for cardiac
resynchronised therapy (CRT) [23]. But better, more
efficient criteria for CRT are still being sought. 
The degree of LA and LAA function impairment
might become in future useful clues to qualify
patients with CHF for CRT.
As we know there have been no clinical studies
on the mutual interaction between BBBs and LA
and LAA function. That is why we assessed and
compared LA and LAA systolic function in patients
with post-myocardial left bundle branch block
(LBBB), right bundle branch block (RBBB) and left
anterior hemiblock (LAHB), and compared the data
to those of patients after MI with no conduction
disturbances as well as to healthy subjects. 
Material and methods
Study population
The study group comprised 59 patients with
persistent post-myocardial distal blocks. They were
allocated to one of the three following subgroups:
study group I – 20 patients with LBBB; study group
II – 20 patients with RBBB; study group III – 19
patients with LAHB. Control groups consisted of
patients with MI in their history and no intracardiac
conduction disturbances (19 patients – group IV) and
clinically healthy people (16 patients – group V). 
Patients with BBBs other than post-myocardial
aetiology were not entered into the study. The
patients were included only if they had had ECG
records done within 6 months before MI and had
no BBBs. That made it highly probable that
conduction disturbances were the effects of MI.
Patients with congenital and significant valvular
anomalies, with heart rhythm disturbances, with
acute and chronic pulmonary disease, with
anaemia, with hypo- and hyperthyreosis and with
neoplastic diseases were excluded from the study.
Patients with echocardiographically documented
ventricular hypertrophy were not admitted to the
study either. 
The study protocol was approved by the Ethics
Committee of the Medical University of Lodz,
Poland. All patients signed informed consent prior
to inclusion in the study.
Echocardiography
All enrolled patients underwent transthoracic
and transoesophageal echocardiography. Inves  ti  ga  -
tions were performed with a 1.7-3.5 MHz transducer
(Acuson) connected to an Acuson Sequoia 512 and
with a multiplane transducer 5.5 MHz connected to
the same echocardiography system. Each parameter
was calculated twice and the averaged values were
analysed.
Transthoracic echocardiography
The routine parasternal long and short axis
views as well as four-chamber and two-chamber
views were used to measure the parameters.
Simultaneously to echocardiography one ECG lead
record was performed.
M-mode echocardiography (left atrial
parameters)
From M-mode in parasternal long axis view the
following parameters of the left atrium were
measured: (1) LA maximum dimension (LAmax.),
measured just after the T wave, (2) LA minimum
dimension (LAmin.), measured just before the QRS
complex, (3) LA pre-systolic dimension (LAa),
measured at the peak of the P  wave of the
simultaneously recorded ECG [24].
On the basis of these three parameters the
following four LA indexes describing its
haemodynamic function were calculated [24, 25].












Echocardiographic parameters of LA:
2D LA parameters: LAinfero-posterior, LAmedio-lateral –
dimensions measured in four-chamber apical view
at the end of the LA systole. 
Multiplying the latter two dimensions by each
other (LAinfero-posterior × LAmedio-lateral) LA area was
calculated (LAarea).
Doppler parameters of LA function:
From trans-mitral flow the following parameters
were determined by means of pulsed Doppler
method:
PEP LA – pre-ejection period of LA – time interval
measured from the beginning of the P-wave in
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the A (atrial) wave in pulsed Doppler spectrum
power of transmitral flow. 
ET LA ejection time of LA – time interval between
the beginning and the end of the A (atrial) wave in
pulsed Doppler spectrum power of transmitral flow. 
PEP/ET LA index – calculated as PEP LA/ET LA
[25-26].
Pulmonary venous flow parameters
The flow in the upper right pulmonary vein was
analysed. The pulsed Doppler sample volume was
placed 0.5 to 1.0 cm in the orifice of the upper right
pulmonary vein into the left atrium. The vein was
visualized by a slightly cephalic elevation of the
interrogation plane from a standard four-chamber
view. We analysed peak velocity of retrograde (PVR)
(atrial) pulmonary venous flow [29, 30] as the
parameter describing LA systolic function.
Transthoracic echocardiography 2D left
ventricular parameters: LVEDd – left ventricular end-
diastolic volume, LVESd – left ventricular end-
systolic volume, LVEF – left ventricular ejection
fraction, measured according to Simpson’s formula.
Transthoracic Doppler echocardiography of
mitral flow 
Mitral flow was recorded between the mitral
leaflets in the four-chamber view. The following
parameters were analysed from the velocity
tracings: E – early mitral flow peak velocity, A – atrial
flow peak velocity, DT – deceleration time of E wave,
E/A – early mitral/atrial flow peak velocities index
[31], IVRT – isovolumic relaxation time of left
ventricle. 
Transoesophageal echocardiography left atrial
appendage parameters
The following LAA parameters were analysed: 
– LAA transversal dimension (LAAtrans.) i.e. 
– LAA longitudinal dimension (LAAlong.) i.e. 
– LAA maximal (LAAarea max.) i.e. diastolic area –
measured at the onset of P wave of ECG 
LAA minimal (LAAarea min.) i.e. systolic area –
measured just after R wave of QRS complex of 
ECG [32]. 
The LAA ejection fraction (EFLAA) was calculated
as maximal area minus minimal area divided by the
maximal area: 
EFLAA =
LAA max. area – LAA min. area
LAA max. area
The LAA blood flow velocity was obtained by
placing the pulsed Doppler sample volume into the
outlet of the appendage blood cavity > 1 cm away
from the left atrial cavity. The peak LAA emptying
(LAAE) and the peak LAA filling (LAAF) velocities
were recorded as described previously [33-35]. LAAE
[m/s]-left atrial appendage (LAA) peak emptying
velocity was obtained in the left atrial appendage
long-axis view with the sample volume placed 0.5-
1.0 cm within the appendage outlet. 
LAAF [m/s]-LAA peak filling velocity – measured
in the same way as LAAE.
Statistical analysis
Data are reported as mean ± SD. A p-value < 0.05
was considered significant. The following tests for
statistical significance were used: (1) for dependent
variables: Student’s t-test if the distribution was
normal, Wilcoxon’s test if the distribution of at least
one of the characters differed from normal, (2) for
independent variables: Student’s t-test if the
variances were equal and the distribution of the
character was normal, Cochran’s test if the variances
were not equal and the distribution of the character
was normal, Mann-Whitney test or Kolmogorov-
Smirnov test if the distribution of at least one of the
characters differed from normal. The Kolmogorov-
Smirnov test was used to assess whether the
distribution of the analysed character was normal. 
Results
Study group I – comprised 13 women and 7 men
aged from 53 to 77 years (mean 67.6 ±9.96). Study
group II: 9 women and 11 men aged from 52 to 
85 years (mean 71.4 ±8.88). Study group III: 
4 women and 15 men aged from 54 to 79 years
(mean 68.95 ±9.24). Every patient experienced MI
at least 6 weeks before inclusion in the study and
had the proper level of myocardial necrosis markers
(creatine kinase-MB fraction [CK-MB] and troponins)
at the time of inclusion. In group I 15 patients had
anterior, 3 infero-lateral MI. In group II 12 patients
had anterior; 2 antero-lateral; 4 lateral; 2 inferior MI.
In group III 8 patients had anterior; 9 inferior and 
3 lateral MI. All patients had sinus rhythm in ECG
Holter monitoring. Sinus rhythm was necessary to
be included in the study. 
Forty-two patients had hyperlipidaemia, 
36 hypertension, 27 were addicted smokers, 22 had
positive family history, 3 diabetes mellitus (DM) type
2 and 4 obesity. A precise description of the risk
factors in particular groups is presented in Table I.
Groups IV and V constituted control groups.
Patients of group IV (16) experienced MI at least 
6 weeks before inclusion in the study and had no
His-Purkinje system disturbances. All the individuals
had q-wave MI; 7 anterior; 5 inferior; 3 lateral; 
1 apical MI. There were 10 men and 6 women in the
group aged from 45 to 96 years (mean 63.94
±12.75). Group V comprised 14 clinically healthy
people: 8 men and 6 women, aged from 24 to 69
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changes in the coronary arteries.
LAmax., LAmin., and LAa were significantly higher
in groups I-IV than in group V. But they did not differ
significantly between groups I-IV. There were no
significant differences as to FAE LA and FPE LA
between groups I-V. The values of FTE LA in groups
II and III were significantly higher than in group V.
All the results are presented in Tables II-IV.
E was significantly higher in group I than in
groups II, III, IV, did not differ from group V, while
the values in groups II, III, IV were significantly lower
than in group V. A was significantly higher in groups
II, III, IV than in group V. A in group I did not
significantly differ from other groups. E/A ratio was
significantly lower in groups II and IV than in group
V. DT was significantly shorter in groups II and III
than in group IV, and significantly longer in group
IV than in group V. 
PEP LA was significantly longer in group I than in
groups III and IV while it was significantly shorter in
groups III and IV than in group V. ET LA was
significantly shorter in group IV and it was
significantly longer in groups III and IV than in group
V. In group II ET was significantly longer than in group
V, significantly shorter than in group IV, and did not
differ from the other groups. PEP/ET LA index was
significantly higher in group I than in groups III and
IV, and in group II as compared with IV. It was
significantly lower in groups II, III, IV than in group V. 
PVR was significantly higher in groups I, II, III, IV
than in group V. 
Parameters of LAA systolic function
LAAtrans. was significantly higher in group I than
in group V. LAAlong. was significantly higher in group
I than in groups II, III, V and it was significantly
Group I Group II Group III Group IVG roup VA ll
Dyslipidaemia 12 11 5 11 3 42
Hypertension 13 10 6 7 0 36
Smoking 8945 1 2 7
Positive family history 7842 1 2 2
Obesity 11200 4
Diabetes mellitus 11010 3
Table I. Clinical characteristics of study groups
Group I Group II Group III Group IVG roup V
LAmax. [cm] 3.85 ±0.64V 3.74 ±0.44V 3.76 ±0.42V 3.77 ±0.44V 3.13 ±0.40 
LAmin. [cm] 2.69 ±0.78V 2.65 ±0.44V 2.70 ±0.58V 2.50 ±0.62V 2.05 ±0.31
LAa [cm] 3.25 ±0.72V 3.12 ±0.49V 3.26 ±0.47V 3.06 ±0.52V 2.54 ±0.32
FAE 0.18 ±0.11 0.17 ±0.09 0.15 ±0.08 0.19 ±0.09 0.19 ±0.07
FPE 0.16 ±0.08 0.17 ±0.08 0.14 ±0.05IV. V 0.19 ±0.09 0.19 ±0.05
FTE 0.31 ±0.11 0.29 ±0.09V 0.28 ±0.10V 0.35 ±0.10 0.35 ±0.06
E [m/s] 0.82 ±0.26II .III. IV 0.62 ±0.20V 0.65 ±0.17V 0.66 ±0.17V 0.80 ±0.12
A [m/s] 0.76 ±0.32 0.78 ±0.22V 0.80 ±0.27V 0.77 ±0.26V 0.57 ±0.14
E/A 1.28 ±0.75 0.90 ±0.49V 1.03 ±0.90 0.93 ±0.35V 1.45 ±0.33
DT [ms] 177.75 ± 78.54 157.52 ± 69.67IV 159.53 ±86.93IV 221.69 ±74.31V 162.07 ±12.48
IVRT [ms] 103.35 ± 39.51 98.30 ± 29.96 107.47 ±34.51 101.13 ±27.92 90.21 ±16.08
PEPLA [ms] 88.40 ± 46.97III. IV 71.60 ± 28.49 62.88 ±14.54V 62.20 ±15.09V 76.57 ±12.04
ET [ms] 145.90 ±49.57IV 154.35 ±33.69IV. V 173.32 ±67.69V 189.94 ±48.50V 128.43 ±15.93
PEP/ET 0.66 ±0.44III. IV 0.48 ±0.19IV. V 0.41 ±0.18V 0.35 ±0.12V 0.60 ±0.11
PVR [m/s] 0.33 ±0.14V 0.35 ±0.13V 0.35 ±0.11V 0.31 ±0.09V 0.19 ±0.02
Table II. Echocardiographic parameters of left atrium
LAmax. – LA maximum dimension, LAmin. – LA minimum dimension, LAa – LA pre-systolic dimension, FAE – active emptying fraction of LA, 
FPE – passive emptying fraction of LA, FTE – total emptying fraction of LA, E – early mitral flow peak velocity, A – atrial flow peak velocity
DT – deceleration time, IVRT – isovolumic relaxation time of left ventricle, PEPLA – pre-ejection period of LA, ET – ejection time of LA, 
PEP/ET – PEP/ET index, PVR – peak velocity of retrograde (atrial) pulmonary venous flow
II, III, IV, V – Group number under a parameter value indicates significant difference with that group. Statistical significance p < 0.05
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LAAlong [cm] 4.37 ±0.72V 3.75 ±0.69 3.63 ±1.03 3.60 ±1.01 3.11 ±0.69
LAAtrans [cm] 1.59 ±0.39II. III. V 1.53 ±0.53V 1.56 ±0.38 1.6 ±0.26 1.32 ±0.25
LAAarea max. [cm2] 4.41 ±1.67V 3.8 ±1.43 3.43 ±1.91 3.58 ±2.56 3.1 ±0.87
LAAarea min. [cm2] 1.79 ±1.08 1.3 ±0.94 1.34 ±1.27 1.54 ±1.35 2.08 ±0.68
EFLAA [%] 47.37 ±17.91II. V 33.7 ±13.67V 35.99 ±17.91V 39.45 ±9.55V 33.29 ±8.28
LAAE [m/s] 0.74 ±0.22II. V 0.53 ±0.23 0.57 ±0.35 0.81 ±0.06V 0.41 ±0.04
LAAF [m/s] 0.61 ±0.18II. III. V 0.44 ±0.12 0.44 ±0.21 0.49 ±0.06 0.42 ±0.05
Table III. Echocardiographic parameters of left atrial appendage
LAAlong. – left atrial appendage longitudinal dimension, LAAtrans – left atrial appendage transversal dimension, LAAarea max. – left atrial appendage
maximal area, LAAarea min. – left atrial appendage minimal area, EFLAA – left atrial appendage ejection fraction, LAAE – left atrial appendage
maximal empting velocity, LAAF – left atrial appendage maximal filling velocity
II, III, IV, V – Group number under a parameter value indicates significant difference with that group. Statistical significance p < 0.05
Group I Group II Group III Group IVG roup V
LVEDd [cm] 5.56 ±0.82V 5.54 ±0.95V 5.44 ±0.89 5.47 ±0.67V 4.92 ±0.43
LVESd [cm]  4.26 ±0.80IV. V 4.06 ±1.29V 3.7 ±1.05V 3.57 ±0.72V 2.76 ±0.43
LVEF [%] 34.75 ±11.59IV. V 40.3 ±9.58IV. V 37.53 ±8.85IV. V 47.25 ±9.66V 58.83 ±4.85
Table IV. Left ventricular parameters
LVEDd – left ventricular end-diastolic dimension, LVESd – left ventricle end-systolic dimension, LVEF – left ventricular ejection fraction
IV, V – Group number under a parameter value indicates significant difference with that group. Statistical significance p < 0.05 
higher in group II than in group V. LAAarea max. was
significantly higher in group I than in group V.
LAAarea min. was significantly lower in group III than
in V. 
EFLAA was significantly higher in groups I, II, III,
IV than in group V and it was significantly higher
in group I than in group II. 
LAAE was significantly higher in group I than in
groups II and V as well as in group IV than in group
V. LAAF was significantly higher in group I than in
groups II, III, V. 
LVEDd was significantly higher in groups I, II, IV
than in group V. LVESd was significantly higher in
groups I, II, III, IV than in group V; it was also
significantly higher in group I than in group IV. EF
was significantly lower in groups I, II, III, IV than in
group V. In groups I, II, III EF was significantly lower
than in group IV.
Discussion
Echocardiography is a widely used and accepted
method for LA function evaluation. In the study we
assessed systolic LA and LAA function in patients
after MI complicated with BBBs.
As far as we know, nobody has investigated LA
and LAA systolic function in post-MI BBBs in
a clinical context until now.
Our findings indicate that LA compensates LV
deterioration after MI, but the presence of post-
myocardial intra-ventricular conduction distur  bances
impairs the compensatory mechanisms. The more
advanced conduction disturbances were observed,
the more was compensation impaired. In patients
who had MI with no conduction disturbances in the
His-Purkinje system the LA systolic function
enhancement was most expressed. The compen  -
satory mechanism was also observed in patients
with post-myocardial LAHB and RBBB but to a far
lesser degree. Analysis of echocardio  graphic para  -
meters showed no enhancement but rather
a tendency towards deterioration of LA systolic
function in patients with post-myocardial LBBB (group
I) as compared to healthy individuals (group V). 
It is widely known that the LA contributes as
a pump in the LV filling increase after MI and this
is a compensatory mechanism to LV function
deterioration due to post-infarction myocardial
damage [36-38]. LA and LV function are strictly
associated with each other – they cooperate
mutually. There are observations that LV function
deterioration results in LA systolic function
enhancement [37]. It happens in congestive heart
failure as after MI [39] and in congestive
cardiomyopathies. The LA works as a “booster
pump”, compensating LV systolic function loss to
support cardiac output [38].
The enhancement of LA systolic function was
observed in patients with post-myocardial RBBB
and LAHB (group II and group III), as compared to
healthy individuals (group V).
There is evidence that LV function is impaired in
patients with LBBB as compared with individuals
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associated with higher LVEDd, lower EF, and longer
IVRT [1, 41]. These indicate that LBBB affects systolic
as well as diastolic function. In our study the
parameters of LV systolic function (LVEDV, LVESd,
EF) showed significantly worse LV systolic function
in patients with BBBs as compared with subjects
after MI and no conduction disturbances (group IV)
as well as compared with healthy subjects (group V).
But there were no significant differences in LV
systolic function parameters between groups of
patients with different conduction disturbances.
Meanwhile, most parameters describing LA systolic
function showed significant differences between
analysed groups of patients. Generally speaking,
patients with post-MI RBBB and LAHB had more
enhanced LA systolic function than patients with
post-MI LBBB.
We conclude that LA systolic function and the
parameters describing it are probably more
sensitive than LV systolic function and its
parameters to heart overload. That is why despite
no significant differences among LV function
parameters in patients with RBBB and LAH, the
parameters of LA presented less enhanced systolic
function in patients with RBBB compared with LAH.
According to the results of our study the
compensatory mechanism of LA enhancement that
occurs in response to LV function impairment
seems to be reduced by intracardiac conduction
disturbances. The more severely conductance was
impaired the more the effect of diminishing of the
LA compensation in LA systolic parameters was
visible. In patients with post-MI LBBB LA systolic
function was observed not to be enhanced but it
showed even a tendency to be deteriorated as
compared with patients who had MI with no
conductance disturbances. In patients with post-
MI RBBB and LAHB enhancement of LA systolic
function seemed to have been less expressed than
in patients with MI and no BBBs. RBBB and LAHB
reduced LA systolic compensation but definitely to
a lesser degree than LBBB.
Conductance disturbances in the His-Purkinje
system resulting from MI are additional factors,
together with post-myocardial scar, that impair left
ventricular function. In our study, patients with
post-MI LBBB had the worst LV systolic function
(the lowest EF). In these patients LA systolic
function could have been expected to be mostly
enhanced. However, we observed the contrary
phenomenon. 
LV impairment causes LV end diastolic pressure
to increase. The pressure in the LA chamber
increases as well. The LA like the LV works according
to Frank-Starling’s law. LA contraction is determined
by the length of the atrial fibres, i.e. by the pressure
existing in the LA chamber just prior to its systole
[42-44]. During ventricular diastole, the LA is directly
exposed to LV pressures through the open mitral
valve [45]. The higher the LA pressure, the stronger
the LA muscle fibre contractions and the greater the
volume expelled from the LA to the LV chamber.
However, this compensatory mechanism is limited
to some degree. If the LA pressure exceeds 
the higher limit of Frank-Starling’s law the
compensatory mechanisms fail [24, 46]. In patients
with LBBB LV function was impaired the most
severely, which resulted in the highest LV end
diastolic and LA pressure. The values of LA pressure
might have exceeded the upper limit within which
Frank-Starling’s law operates.
Another explanation of the observed reduction
of LA compensation in post-MI LBBB might be the
fact that BBBs disrupt LA and LV mutual
haemodynamic cooperation. The effectiveness of
atrial systole in augmenting ventricular output
depends on the time relationship between atrial
and ventricular systole.
The more the intracardiac conductance was
impaired, the more were disintegration of LV systole
and visible reduction of LA compensation observed. 
The presence of LBBB was not associated with
any LAA systolic function deterioration (in contrast
to the LA systolic function). In group I LAA planimetric
parameters describing its size had the highest values
among the study groups: LAAlong., LAAarea max.,
LAAarea min., EFLAA. Also Doppler parameters had the
highest values in group I. LAAE was higher only in
the patients in group IV – individuals who had MI
with no conduction disturbances. 
There was not observed any harmful
haemodynamic effect of BBBs on LAA systolic
function. All LAA parameters indicated LAA systolic
function enhancement; this was the case also in
patients with post-MI LBBB. In this group the LAA
systolic function was the most enhanced. 
The LAA is a highly autonomic chamber that
differs in many aspects from the LA. The LAA has
quite distinct anatomy and physiology from the LA
[47, 49]. The LAA contractile pattern differs from
that of the main LA body [50]. The LAA shortens to
a greater extent and it is also more distensible than
the body of the LA [51-54]. This autonomy and the
physiological differences between the LAA and the
LA might explain why the LAA reacts differently than
the LA to BBBs.
Our study tries to explain the role that the LA
and LAA plays in the pathophysiology of the heart.
The results of our study suggest how the
cooperation between the LV, LA and LAA occurs
after MI complicated with BBBs. The pattern of
cooperation between the LV, LA and LAA might have
an important impact on numerous clinical aspects
such as physical activity, individual response to CRT,
heart remodelling, and post-myocardial prognosis.
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prognosis [55, 56]. Improvement of left atrial systolic
function after CRT led to reverse LA remodelling
expressed by reduction of LA size [57]. LA and LAA
systolic function changes may help qualify patients
for CRT.
Better and more precise description of the
mutual interactions between heart chambers needs
further studies including larger populations. Clinical
trials are also necessary to define the exact role the
LA and LAA play in heart pathology [58-61].
In conclusion, in patients who experienced MI,
compensatory enhancement of systolic left atrial
function is observed. Post-myocardial BBBs (mainly
LBBB) are elements that reduce systolic left atrial
function enhancement – the phenomenon that
compensates post-myocardial left ventricular
impairment. LA systolic function parameters seem
to be more sensitive than LV systolic function
parameters to heart overload. Post-myocardial LBBB
do not affect systolic left atrial appendage function,
in contrast to systolic left atrial function.
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